These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18228651)

  • 1. Improving outcomes of percutaneous coronary intervention through the application of guidelines and benchmarking: reduction of major bleeding and blood transfusion as a model.
    Chetcuti SJ; Grossman PM; Kline-Rogers EM; Montoye C; Smith D; Moscucci M
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II44-8. PubMed ID: 18228651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in management of acute coronary syndromes: effects of bleeding.
    O'Neill W
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II1-3. PubMed ID: 18228646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention.
    Kim P; Dixon S; Eisenbrey AB; O'Malley B; Boura J; O'Neill W
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II35-43. PubMed ID: 18228650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of defining bleeding among patients with acute coronary syndromes.
    Wallace TW; Rao SV
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II16-23. PubMed ID: 18228648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention.
    Jani SM; Smith DE; Share D; Kline-Rogers E; Khanal S; O'Donnell MJ; Gardin J; Moscucci M
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II49-56. PubMed ID: 18228652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk.
    Manoukian SV; Voeltz MD; Eikelboom J
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II24-34. PubMed ID: 18228649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of anticoagulant and antiplatelet therapy: benefits and risks of contemporary pharmacologic agents and their implications for myonecrosis and bleeding in percutaneous coronary intervention.
    Medina HM; Bhatt DL
    Clin Cardiol; 2007 Oct; 30(10 Suppl 2):II4-15. PubMed ID: 18228647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
    Nakamura M; Yamashita T; Hayakawa A; Matsumoto T; Takita A; Hasegawa C; Uchino K; Sekine T; Iizuka T; Tanabe H; Kogure S
    J Cardiol; 2021 Feb; 77(2):186-194. PubMed ID: 32943280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and blood transfusion: prognostic implications in patients undergoing contemporary percutaneous coronary intervention.
    Moscucci M
    Curr Cardiol Rep; 2009 Sep; 11(5):363-8. PubMed ID: 19709496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study).
    Gupta A; Chui P; Zhou S; Spertus JA; Geda M; Lorenze N; Lee I; D' Onofrio G; Lichtman JH; Alexander KP; Krumholz HM; Curtis JP
    Am J Cardiol; 2015 Jul; 116(1):1-7. PubMed ID: 25937348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
    Brener SJ; Moliterno DJ; Lincoff AM; Steinhubl SR; Wolski KE; Topol EJ
    Circulation; 2004 Aug; 110(8):994-8. PubMed ID: 15302778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of bleeding and blood transfusion in percutaneous coronary intervention.
    Rao SV
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S18-26. PubMed ID: 17917617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R
    Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.
    Doyle BJ; Ting HH; Bell MR; Lennon RJ; Mathew V; Singh M; Holmes DR; Rihal CS
    JACC Cardiovasc Interv; 2008 Apr; 1(2):202-9. PubMed ID: 19463301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention.
    Bertrand OF; Jolly SS; Rao SV; Patel T; Belle L; Bernat I; Parodi G; Costerousse O; Mann T
    Am J Cardiol; 2012 Aug; 110(4):599-606. PubMed ID: 22591669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs.
    Steinhubl SR; Kastrati A; Berger PB
    Am Heart J; 2007 Jul; 154(1):3-11. PubMed ID: 17584547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines for managing coagulation in patients undergoing endoscopic procedures.
    Parras FA
    Rev Esp Enferm Dig; 2010 Feb; 102(2):124-38. PubMed ID: 20361848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.